Mark Kindy to Oligopeptides
This is a "connection" page, showing publications Mark Kindy has written about Oligopeptides.
Connection Strength
0.959
-
GM6 Attenuates Alzheimer's Disease Pathology in APP Mice. Mol Neurobiol. 2019 Sep; 56(9):6386-6396.
Score: 0.588
-
Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics. Biol Chem. 2007 Sep; 388(9):979-83.
Score: 0.265
-
Delta 2-specific opioid receptor agonist and hibernating woodchuck plasma fraction provide ischemic neuroprotection. Acad Emerg Med. 2008 Mar; 15(3):250-7.
Score: 0.069
-
Enzyme-linked immunosorbent assay for an octapeptide based on a genetically engineered fusion protein. Anal Chem. 1993 May 01; 65(9):1147-51.
Score: 0.025
-
RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003 Jul; 9(7):907-13.
Score: 0.012